PepCalcs
    Back to Library

    Pancragen

    Research Use OnlyPreclinical

    Pancragen

    Description

    A pancreatic bioregulator peptide supporting pancreatic tissue health and metabolic function. Important for blood sugar regulation.

    Dose:2 mg
    Frequency:30 days in a row, 2-3x per year
    Administration Method: SQ
    CategoryBioregulator
    Half-LifeVery short (minutes); typical of Khavinson short peptides.

    Overview

    Pancragen is a synthetic structural analog of a peptide isolated from cattle pancreatic cells. It is investigated as a pancreatic bioregulator for aging-related metabolic problems, including effects on insulin and glucagon regulation.

    Mechanism of Action

    Pancragen (KEDW tetrapeptide) is a bioregulator proposed to penetrate cellular membranes and interact with the nucleus and nucleolus, influencing gene transcription involved in pancreatic cell differentiation and potentially affecting gene methylation. It has been reported to decrease pro-apoptotic p53 and increase anti-apoptotic Mcl1, suggesting anti-apoptotic potential.

    Benefits

    • •Pancreas health
    • •Metabolic support
    • •Blood sugar regulation
    • •Tissue regeneration

    Reported Side Effects

    • •Limited human safety data
    • •Possible injection site reactions

    Safety Notes

    Lab use only; not for human use.

    Scientific References

    Related Bioregulator Peptides